Aptus Capital Advisors’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $47.9K | Buy |
|
|||||
|
2025
Q3 | $57.1K | Buy |
|
|||||
|
2025
Q2 | $36.8K | Buy |
|
|||||
|
2025
Q1 | $61.3K | Buy |
|
|||||
|
2024
Q4 | $43.9K | Buy |
|
|||||
|
2024
Q3 | $22.8K | Buy |
|
|||||
|
2024
Q2 | $24.5K | Buy |
|
|||||
|
2024
Q1 | $24.7K | Buy |
|
|||||
|
2023
Q4 | $33K | Buy |
|
|||||
|
2023
Q3 | $29K | Buy |
|
|||||
|
2023
Q2 | $33.5K | Buy |
|
|||||
|
2023
Q1 | $33.6K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $15K | Buy |
|
|||||
|
2022
Q2 | $14K | Buy |
|
|||||
|
2022
Q1 | $12K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $7K | Hold |
|
|||||
|
2019
Q2 | $17K | Buy |
|